BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Lieff Cabraser Reminds St. Jude Medical (STJ) Investors of Upcoming Deadline in Class Action Lawsuit


7/30/2012 7:51:43 AM

SAN FRANCISCO--(BUSINESS WIRE)-- The law firm of Lieff Cabraser reminds investors of the August 13, 2012 deadline to move for appointment as lead plaintiff in the securities class action against St. Jude Medical, Inc. (“St. Jude” or the “Company”) (STJ), brought on behalf of all persons who purchased the securities of St. Jude between December 15, 2010 and April 4, 2012, inclusive (the “Class Period”).

If you purchased the securities of St. Jude during the Class Period, you may move the Court for appointment as lead plaintiff by no later than August 13, 2012. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Your share of any recovery in the action will not be affected by your decision of whether to seek appointment as lead plaintiff. You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.

St. Jude shareholders who wish to learn more about the action and how to seek appointment as lead plaintiff should click here or contact Sharon Lee of Lieff Cabraser toll-free at (800) 541-7358.

The Complaint charges St. Jude and its Chairman, Chief Executive Officer, and President with violations of the Securities Exchange Act of 1934. The Complaint alleges that the defendants failed to disclose that St. Jude’s Riata and Riata ST defibrillator leads were associated with short circuits and protruding wires, and that the Company’s QuickSite and QuickFlex Left-Ventricular leads also suffered from protruding wires. During the Class Period, defendants disclosed that the Riata and Riata ST leads had been observed to wear through their silicone casing and protrude into the body. St. Jude subsequently discontinued sales of those leads but defendants failed to disclose that they were also associated with short circuits unrelated to the protruding wires.

On April 4, 2012, the defendants finally disclosed that the QuickSite and QuickFlex Left-Ventricular leads had the same protruding wire defect as the Riata and Riata ST leads. Sales of the QuickSite and QuickFlex leads were also discontinued. Following these disclosures, the closing price of St. Jude’s stock fell from $43.80 to $38.91 over three trading days, a decline of over 11%.

About Lieff Cabraser

Lieff Cabraser is a nationally recognized law firm committed to advancing the rights of investors and promoting corporate responsibility.

Since 2003, the National Law Journal has selected Lieff Cabraser as one of the top plaintiffs’ law firms in the nation. In compiling the list, the National Law Journal examined recent verdicts and settlements in addition to overall track records. Lieff Cabraser is one of only two plaintiffs’ law firms in the United States to receive this honor for the last nine consecutive years.

For more information about Lieff Cabraser and the firm’s representation of investors, please visit http://www.lieffcabraser.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lieff Cabraser Heimann & Bernstein, LLP

Sharon Lee, 415-956-1000



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES